Variant	GeneSymbol	VariationID	AlleleID	Type	Name	GeneSymbol	LastEvaluated	PhenotypeList	NumberSubmitters	chr	pos	REF	ALT	last_evaluated	n_called	n_not_called	AC	n_het	flag_HC_lab_unspecified_phenotype	high_confidence_lab_2017_any	high_confidence_lab_2017_clinical_significance	variant_str	assessment1	assessment1_notes	assessment2	Level	Notes	Traits2-21230565-G-A	APOB	69508	80399	single nucleotide variant	NM_000384.2(APOB):c.9175C>T (p.Arg3059Cys)	APOB	16-Oct-17	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1"	4	2	21230565	G	A	10/16/17	46845	118	1	1	FALSE	TRUE	"Likely pathogenic, Uncertain significance"	2:21230565:G:A	VUS	"High Confidence Lab's conflicted, reassessed as VUS"	NA	VUS	"High Confidence Lab's conflicted, and reassessed because of high allele count,  reassessed as VUS"	High LDL2-21229160-C-T	APOB	17890	32929	single nucleotide variant	NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)	APOB	11-Jul-18	"Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided"	17	2	21229160	C	T	6/22/18	46952	11	12	12	FALSE	TRUE	"Pathogenic, Pathogenic, Pathogenic"	2:21229160:C:T	NA	NA	NA	Pathogenic	NA	High LDL2-21229161-G-A	APOB	40223	48709	single nucleotide variant	NM_000384.2(APOB):c.10579C>T (p.Arg3527Trp)	APOB	3-Jul-18	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1;not provided"	8	2	21229161	G	A	7/3/18	46952	11	14	14	FALSE	TRUE	"Pathogenic, Pathogenic, Pathogenic"	2:21229161:G:A	NA	NA	NA	Pathogenic	NA	High LDL19-11222182-T-C	LDLR	36451	45114	single nucleotide variant	NM_000527.4(LDLR):c.1061-8T>C	LDLR	31-May-18	Familial hypercholesterolemia;not specified	14	19	11222182	T	C	1/22/18	46781	182	427	421	TRUE	TRUE	Benign	19:11222182:T:C	NA	NA	NA	Benign	NA	High LDL19-11231203-G-A	LDLR	36460	45123	single nucleotide variant	NM_000527.4(LDLR):c.2140+5G>A	LDLR	26-Jan-18	Familial hypercholesterolemia;not specified	13	19	11231203	G	A	1/26/18	46135	828	476	468	TRUE	TRUE	Benign	19:11231203:G:A	NA	NA	NA	Benign	NA	High LDL19-11221357-G-A	LDLR	161263	171207	single nucleotide variant	NM_000527.4(LDLR):c.970G>A (p.Gly324Ser)	LDLR	5-Oct-17	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	11	19	11221357	G	A	10/5/17	46508	455	186	186	TRUE	TRUE	Benign	19:11221357:G:A	NA	NA	NA	Benign	NA	High LDL19-11218079-G-A	LDLR	183097	181238	single nucleotide variant	NM_000527.4(LDLR):c.829G>A (p.Glu277Lys)	LDLR	29-Dec-17	Familial hypercholesterolemia;Familial hypercholesterolemia;not provided;not specified	12	19	11218079	G	A	12/29/17	46959	4	61	61	TRUE	TRUE	Benign	19:11218079:G:A	NA	NA	NA	Benign	NA	High LDL19-11222300-G-A	LDLR	183138	181250	single nucleotide variant	NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr)	LDLR	18-Aug-17	Familial hypercholesterolemia;not provided;not specified	15	19	11222300	G	A	8/18/17	46749	214	4474	3894	TRUE	TRUE	Benign	19:11222300:G:A	NA	NA	NA	Benign	NA	High LDL19-11221324-G-A	LDLR	224619	226399	single nucleotide variant	NM_000527.4(LDLR):c.941-4G>A	LDLR	12-Jan-18	Familial hypercholesterolemia	9	19	11221324	G	A	1/12/18	46867	96	399	389	FALSE	TRUE	Benign	19:11221324:G:A	NA	NA	NA	Benign	NA	High LDL19-11223961-C-T	LDLR	224620	226400	single nucleotide variant	NM_000527.4(LDLR):c.1194C>T (p.Ile398=)	LDLR	2-Jan-18	Familial hypercholesterolemia	5	19	11223961	C	T	1/2/18	46593	370	134	134	FALSE	TRUE	Benign	19:11223961:C:T	NA	NA	NA	Benign	NA	High LDL19-11230809-C-T	LDLR	237868	243276	single nucleotide variant	NM_000527.4(LDLR):c.1887C>T (p.Phe629=)	LDLR	8-Jan-18	Familial hypercholesterolemia	2	19	11230809	C	T	1/8/18	46963	0	149	147	FALSE	TRUE	Benign	19:11230809:C:T	NA	NA	NA	Benign	NA	High LDL19-11210979-G-T	LDLR	68099	78990	single nucleotide variant	NM_000527.4(LDLR):c.148G>T (p.Ala50Ser)	LDLR	30-Nov-17	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	13	19	11210979	G	T	11/30/17	46963	0	43	43	FALSE	TRUE	Likely benign	19:11210979:G:T	NA	NA	NA	Likely Benign	NA	High LDL19-11240240-G-A	LDLR	161278	171223	single nucleotide variant	NM_000527.4(LDLR):c.2441G>A (p.Arg814Gln)	LDLR	17-Nov-17	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	9	19	11240240	G	A	11/17/17	46961	2	50	50	FALSE	TRUE	Likely benign	19:11240240:G:A	NA	NA	NA	Likely Benign	NA	High LDL19-11217352-G-A	LDLR	161279	171202	single nucleotide variant	NM_000527.4(LDLR):c.806G>A (p.Gly269Asp)	LDLR	17-Oct-17	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	13	19	11217352	G	A	10/17/17	46958	5	33	33	FALSE	TRUE	Likely benign	19:11217352:G:A	Benign	"Functional studies show no damaging effect, Lack of segregation in affected members of a family, observed in cis with a pathogenic variant, Allele frequency is greater than expected for disorder"	NA	Likely Benign	"Functional studies show no damaging effect, Lack of segregation in affected members of a family, observed in cis with a pathogenic variant, Allele frequency is greater than expected for disorder"	High LDL19-11223989-G-A	LDLR	36453	45116	single nucleotide variant	NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys)	LDLR	23-Jan-18	Familial hypercholesterolemia;Hypercholesterolaemia	12	19	11223989	G	A	1/23/18	46789	174	1	1	FALSE	TRUE	Likely pathogenic	19:11223989:G:A	NA	NA	NA	Likely Pathogenic	NA	High LDL19-11223968-C-G	LDLR	161267	171211	single nucleotide variant	NM_000527.4(LDLR):c.1201C>G (p.Leu401Val)	LDLR	11-May-18	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	10	19	11223968	C	G	5/11/18	46713	250	3	3	FALSE	TRUE	Likely pathogenic	19:11223968:C:G	NA	NA	NA	Likely Pathogenic	NA	High LDL19-11218112-G-A	LDLR	161268	171204	single nucleotide variant	NM_000527.4(LDLR):c.862G>A (p.Glu288Lys)	LDLR	1-May-18	Familial hypercholesterolemia;Hypercholesterolaemia	11	19	11218112	G	A	5/1/18	46961	2	8	8	FALSE	TRUE	Likely pathogenic	19:11218112:G:A	NA	NA	NA	Likely Pathogenic	NA	High LDL19-11224005-C-T	LDLR	161276	171212	single nucleotide variant	NM_000527.4(LDLR):c.1238C>T (p.Thr413Met)	LDLR	23-Oct-17	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	9	19	11224005	C	T	10/23/17	46823	140	3	3	FALSE	TRUE	Likely pathogenic	19:11224005:C:T	NA	NA	NA	Likely Pathogenic	NA	High LDL19-11224284-G-A	LDLR	161277	171213	single nucleotide variant	NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg)	LDLR	26-Apr-18	Familial hypercholesterolemia;Hypercholesterolaemia	13	19	11224284	G	A	4/26/18	46777	186	3	3	FALSE	TRUE	Likely pathogenic	19:11224284:G:A	NA	NA	NA	Likely Pathogenic	NA	High LDL19-11227612-C-T	LDLR	161290	171218	single nucleotide variant	NM_000527.4(LDLR):c.1783C>T (p.Arg595Trp)	LDLR	24-Oct-17	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	11	19	11227612	C	T	10/24/17	46963	0	2	2	FALSE	TRUE	Likely pathogenic	19:11227612:C:T	NA	NA	NA	Likely Pathogenic	NA	High LDL19-11227549-C-T	LDLR	183123	181265	single nucleotide variant	NM_000527.4(LDLR):c.1720C>T (p.Arg574Cys)	LDLR	11-Dec-17	Familial hypercholesterolemia;not provided	6	19	11227549	C	T	12/11/17	46963	0	1	1	FALSE	TRUE	Likely pathogenic	19:11227549:C:T	Likely Pathogenic	High Confidence Lab	NA	Likely Pathogenic	High Confidence Lab	High LDL19-11226874-A-G	LDLR	224616	226401	single nucleotide variant	NM_000527.4(LDLR):c.1691A>G (p.Asn564Ser)	LDLR	24-Apr-18	Familial hypercholesterolemia	5	19	11226874	A	G	4/24/18	46954	9	5	5	FALSE	TRUE	Likely pathogenic	19:11226874:A:G	VUS	Insufficient evidence	NA	Likely Pathogenic	Insufficient evidence	High LDL19-11215919-G-A	LDLR	237872	243268	single nucleotide variant	NM_000527.4(LDLR):c.337G>A (p.Glu113Lys)	LDLR	8-Feb-18	Familial hypercholesterolemia	4	19	11215919	G	A	2/8/18	46753	210	2	2	FALSE	TRUE	Likely pathogenic	19:11215919:G:A	VUS	Insufficient evidence	NA	Likely Pathogenic	Insufficient evidence	High LDL19-11227550-G-A	LDLR	251996	246297	single nucleotide variant	NM_000527.4(LDLR):c.1721G>A (p.Arg574His)	LDLR	3-Jul-18	Familial hypercholesterolemia	4	19	11227550	G	A	7/3/18	46963	0	3	3	FALSE	TRUE	Likely pathogenic	19:11227550:G:A	NA	NA	NA	Likely Pathogenic	NA	High LDL19-11231154-C-T	LDLR	252219	246513	single nucleotide variant	NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu)	LDLR	9-Oct-17	Familial hypercholesterolemia;Familial hypercholesterolemias	10	19	11231154	C	T	10/9/17	46657	306	6	6	FALSE	TRUE	Likely pathogenic	19:11231154:C:T	NA	NA	NA	Likely Pathogenic	NA	High LDL19-11224443-G-C	LDLR	440652	434303	single nucleotide variant	NM_000527.4(LDLR):c.1586+5G>C	LDLR	30-May-17	Familial hypercholesterolemia;Familial hypercholesterolemias	3	19	11224443	G	C	5/30/17	46682	281	4	4	FALSE	TRUE	Likely pathogenic	19:11224443:G:C	Likely Pathogenic	High Confidence Lab	NA	Likely Pathogenic	High Confidence Lab	High LDL19-11218160-G-A	LDLR	3692	18731	single nucleotide variant	NM_000527.4(LDLR):c.910G>A (p.Asp304Asn)	LDLR	10-Apr-18	Familial hypercholesterolemia;Hypercholesterolaemia;Inborn genetic diseases	10	19	11218160	G	A	4/10/18	46952	11	3	3	FALSE	TRUE	"Likely pathogenic, Pathogenic"	19:11218160:G:A	NA	NA	NA	Likely Pathogenic	NA	High LDL19-11230758-G-T	LDLR	252072	246373	single nucleotide variant	NM_000527.4(LDLR):c.1846-10G>T	LDLR	29-Aug-17	Familial hypercholesterolemia;not specified	3	19	11230758	G	T	8/29/17	46963	0	3	3	TRUE	FALSE	NA	19:11230758:G:T	NA	NA	Likely Benign	Likely Benign	NA	High LDL19-11222296-G-A	LDLR	256365	256754	single nucleotide variant	NM_000527.4(LDLR):c.1167G>A (p.Thr389=)	LDLR	30-Mar-17	Familial hypercholesterolemia;not specified	2	19	11222296	G	A	3/30/17	46794	169	19	19	FALSE	FALSE	NA	19:11222296:G:A	NA	NA	Likely Benign	VUS	NA	High LDL19-11210996-C-G	LDLR	369857	354078	single nucleotide variant	NM_000527.4(LDLR):c.165C>G (p.Gly55=)	LDLR	NA	Familial hypercholesterolemia	2	19	11210996	C	G	NA	46963	0	7	7	FALSE	FALSE	NA	19:11210996:C:G	NA	NA	Likely Benign	Likely Benign	NA	High LDL19-11221456-C-T	LDLR	369861	354091	single nucleotide variant	NM_000527.4(LDLR):c.1060+9C>T	LDLR	NA	Familial hypercholesterolemia	1	19	11221456	C	T	NA	46930	33	4	4	FALSE	FALSE	NA	19:11221456:C:T	NA	NA	Likely Benign	Likely Benign	NA	High LDL19-11216105-G-A	LDLR	3726	18765	single nucleotide variant	NM_000527.4(LDLR):c.523G>A (p.Asp175Asn)	LDLR	2-Jan-18	Familial hypercholesterolemia	7	19	11216105	G	A	1/2/18	46960	3	2	2	FALSE	FALSE	NA	19:11216105:G:A	NA	NA	Pathogenic	Pathogenic	NA	High LDL19-11217264-G-A	LDLR	200920	198013	single nucleotide variant	NM_000527.4(LDLR):c.718G>A (p.Glu240Lys)	LDLR	22-May-18	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	8	19	11217264	G	A	1/2/18	46962	1	3	3	FALSE	FALSE	NA	19:11217264:G:A	NA	NA	VUS	VUS	NA	High LDL19-11230820-G-A	LDLR	226380	228193	single nucleotide variant	NM_000527.4(LDLR):c.1898G>A (p.Arg633His)	LDLR	28-Nov-17	Familial hypercholesterolemia	7	19	11230820	G	A	11/28/17	46963	0	2	2	FALSE	FALSE	NA	19:11230820:G:A	NA	NA	VUS	VUS	NA	High LDL19-11223984-G-A	LDLR	228798	230981	single nucleotide variant	NM_000527.4(LDLR):c.1217G>A (p.Arg406Gln)	LDLR	30-Mar-17	Familial hypercholesterolemia;not specified	6	19	11223984	G	A	3/30/17	46769	194	1	1	FALSE	FALSE	NA	19:11223984:G:A	NA	NA	VUS	VUS	NA	High LDL19-11216086-C-A	LDLR	251261	245598	single nucleotide variant	NM_000527.4(LDLR):c.504C>A (p.Asp168Glu)	LDLR	25-Mar-16	Familial hypercholesterolemia	2	19	11216086	C	A	3/25/16	46958	5	2	2	FALSE	FALSE	NA	19:11216086:C:A	NA	NA	Likely Pathogenic	VUS	NA	High LDL19-11224381-C-T	LDLR	251886	246200	single nucleotide variant	NM_000527.4(LDLR):c.1529C>T (p.Thr510Met)	LDLR	5-Nov-16	Familial hypercholesterolemia	2	19	11224381	C	T	11/5/16	46948	15	2	2	FALSE	FALSE	NA	19:11224381:C:T	NA	NA	VUS	VUS	NA	High LDL19-11230801-G-A	LDLR	252101	246397	single nucleotide variant	NM_000527.4(LDLR):c.1879G>A (p.Ala627Thr)	LDLR	30-Mar-17	Familial hypercholesterolemia	4	19	11230801	G	A	3/30/17	46963	0	1	1	FALSE	FALSE	NA	19:11230801:G:A	NA	NA	VUS	VUS	NA	High LDL19-11224058-G-A	LDLR	3695	18734	single nucleotide variant	NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr)	LDLR	30-Mar-17	Familial hypercholesterolemia	13	19	11224058	G	A	3/30/17	46933	30	1	1	FALSE	FALSE	NA	19:11224058:G:A	NA	NA	Pathogenic	Pathogenic	NA	High LDL19-11240274-C-G	LDLR	161265	171224	single nucleotide variant	NM_000527.4(LDLR):c.2475C>G (p.Asn825Lys)	LDLR	30-Mar-17	Familial hypercholesterolemia;Hypercholesterolaemia	5	19	11240274	C	G	3/30/17	46961	2	3	3	FALSE	FALSE	NA	19:11240274:C:G	NA	NA	Pathogenic	Pathogenic	NA	High LDL19-11224319-C-G	LDLR	161270	171215	single nucleotide variant	NM_000527.4(LDLR):c.1467C>G (p.Tyr489Ter)	LDLR	25-Mar-16	Familial hypercholesterolemia;Hypercholesterolaemia	3	19	11224319	C	G	3/25/16	46927	36	1	1	FALSE	FALSE	NA	19:11224319:C:G	NA	NA	Pathogenic	Pathogenic	NA	High LDL19-11224296-G-A	LDLR	161284	171214	single nucleotide variant	NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn)	LDLR	11-May-17	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	13	19	11224296	G	A	5/11/17	46771	192	1	1	FALSE	FALSE	NA	19:11224296:G:A	NA	NA	Likely Pathogenic	Likely Pathogenic	NA	High LDL19-11224326-G-A	LDLR	161285	171216	single nucleotide variant	NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn)	LDLR	2-Jan-18	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	13	19	11224326	G	A	1/2/18	46943	20	5	3	FALSE	FALSE	NA	19:11224326:G:A	NA	NA	Pathogenic	Pathogenic	NA	High LDL19-11210912-C-G	LDLR	226304	228117	single nucleotide variant	NM_000527.4(LDLR):c.81C>G (p.Cys27Trp)	LDLR	30-Mar-17	Familial hypercholesterolemia;Familial hypercholesterolemias	10	19	11210912	C	G	3/30/17	46946	17	1	1	FALSE	FALSE	NA	19:11210912:C:G	NA	NA	Pathogenic	Pathogenic	NA	High LDL19-11217342-G-A	LDLR	226334	228147	single nucleotide variant	NM_000527.4(LDLR):c.796G>A (p.Asp266Asn)	LDLR	19-Sep-17	Familial hypercholesterolemia	8	19	11217342	G	A	9/19/17	46962	1	1	1	FALSE	FALSE	NA	19:11217342:G:A	NA	NA	Likely Pathogenic	Likely Pathogenic	NA	High LDL19-11221373-G-A	LDLR	226344	228154	single nucleotide variant	NM_000527.4(LDLR):c.986G>A (p.Cys329Tyr)	LDLR	16-Dec-16	Familial hypercholesterolemia	7	19	11221373	G	A	12/16/16	46672	291	4	4	FALSE	FALSE	NA	19:11221373:G:A	NA	NA	Likely Pathogenic	Likely Pathogenic	NA	High LDL19-11223983-C-T	LDLR	226351	228164	single nucleotide variant	NM_000527.4(LDLR):c.1216C>T (p.Arg406Trp)	LDLR	30-Mar-17	Familial hypercholesterolemia	9	19	11223983	C	T	3/30/17	46756	207	2	2	FALSE	FALSE	NA	19:11223983:C:T	NA	NA	Pathogenic	Pathogenic	NA	High LDL19-11200236-G-A	LDLR	237860	243266	single nucleotide variant	NM_000527.4(LDLR):c.12G>A (p.Trp4Ter)	LDLR	30-Mar-17	Familial hypercholesterolemia	5	19	11200236	G	A	3/30/17	44616	2347	1	1	FALSE	FALSE	NA	19:11200236:G:A	NA	NA	Pathogenic	Pathogenic	NA	High LDL19-11215907-T-C	LDLR	251156	245493	single nucleotide variant	NM_000527.4(LDLR):c.325T>C (p.Cys109Arg)	LDLR	30-Mar-17	Familial hypercholesterolemia	5	19	11215907	T	C	3/30/17	46615	348	4	4	FALSE	FALSE	NA	19:11215907:T:C	NA	NA	Likely Pathogenic	VUS	NA	High LDL19-11221432-C-T	LDLR	251611	245935	single nucleotide variant	NM_000527.4(LDLR):c.1045C>T (p.Gln349Ter)	LDLR	2-Jan-18	Familial hypercholesterolemia	4	19	11221432	C	T	1/2/18	46917	46	1	1	FALSE	FALSE	NA	19:11221432:C:T	NA	NA	Pathogenic	Pathogenic	NA	High LDL19-11224014-G-A	LDLR	251752	246066	single nucleotide variant	NM_000527.4(LDLR):c.1247G>A (p.Arg416Gln)	LDLR	13-Dec-16	Familial hypercholesterolemia;not provided	4	19	11224014	G	A	12/13/16	46800	163	1	1	FALSE	FALSE	NA	19:11224014:G:A	NA	NA	Likely Pathogenic	VUS	NA	High LDL19-11224109-C-T	LDLR	251798	246112	single nucleotide variant	NM_000527.4(LDLR):c.1342C>T (p.Gln448Ter)	LDLR	30-Mar-17	Familial hypercholesterolemia	7	19	11224109	C	T	3/30/17	46914	49	1	1	FALSE	FALSE	NA	19:11224109:C:T	NA	NA	Pathogenic	Pathogenic	NA	High LDL19-11227559-G-A	LDLR	375821	362713	single nucleotide variant	NM_000527.4(LDLR):c.1730G>A (p.Trp577Ter)	LDLR	30-Mar-17	Familial hypercholesterolemia	3	19	11227559	G	A	3/30/17	46963	0	1	1	FALSE	FALSE	NA	19:11227559:G:A	NA	NA	Pathogenic	Pathogenic	NA	High LDL19-11217328-G-T	LDLR	3740	18779	single nucleotide variant	NM_000527.4(LDLR):c.782G>T (p.Cys261Phe)	LDLR	12-Apr-17	Familial hypercholesterolemia;Hypercholesterolaemia	5	19	11217328	G	T	4/12/17	46963	0	1	1	FALSE	FALSE	NA	19:11217328:G:T	VUS	Conflicting evidence	NA	VUS	Conflicting evidence	High LDL19-11217303-C-T	LDLR	161261	171200	single nucleotide variant	NM_000527.4(LDLR):c.757C>T (p.Arg253Trp)	LDLR	30-Mar-17	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	8	19	11217303	C	T	3/30/17	46961	2	28	28	FALSE	FALSE	NA	19:11217303:C:T	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11233991-C-T	LDLR	161262	171222	single nucleotide variant	NM_000527.4(LDLR):c.2282C>T (p.Thr761Met)	LDLR	30-Mar-17	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	9	19	11233991	C	T	3/30/17	46803	160	4	4	FALSE	FALSE	NA	19:11233991:C:T	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11231159-G-A	LDLR	183130	181272	single nucleotide variant	NM_000527.4(LDLR):c.2101G>A (p.Gly701Ser)	LDLR	7-Jun-17	Familial hypercholesterolemia;not provided	7	19	11231159	G	A	6/7/17	46638	325	15	15	FALSE	FALSE	NA	19:11231159:G:A	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11233951-G-A	LDLR	183133	181275	single nucleotide variant	NM_000527.4(LDLR):c.2242G>A (p.Asp748Asn)	LDLR	14-Jun-16	Familial hypercholesterolemia;not provided	5	19	11233951	G	A	6/14/16	46927	36	11	11	FALSE	FALSE	NA	19:11233951:G:A	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11231088-G-T	LDLR	226385	228198	single nucleotide variant	NM_000527.4(LDLR):c.2030G>T (p.Cys677Phe)	LDLR	25-Mar-16	Familial hypercholesterolemia	2	19	11231088	G	T	3/25/16	46215	748	1	1	FALSE	FALSE	NA	19:11231088:G:T	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11216273-T-G	LDLR	251397	245736	single nucleotide variant	NM_000527.4(LDLR):c.691T>G (p.Cys231Gly)	LDLR	5-Nov-16	Familial hypercholesterolemia	4	19	11216273	T	G	11/5/16	44549	2414	1	1	FALSE	FALSE	NA	19:11216273:T:G	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11224008-T-G	LDLR	251747	246061	single nucleotide variant	NM_000527.4(LDLR):c.1241T>G (p.Leu414Arg)	LDLR	25-Mar-16	Familial hypercholesterolemia	3	19	11224008	T	G	3/25/16	46821	142	3	3	FALSE	FALSE	NA	19:11224008:T:G	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11224068-C-T	LDLR	251775	246089	single nucleotide variant	NM_000527.4(LDLR):c.1301C>T (p.Thr434Met)	LDLR	25-Mar-16	Familial hypercholesterolemia	3	19	11224068	C	T	3/25/16	46923	40	2	2	FALSE	FALSE	NA	19:11224068:C:T	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11224443-G-A	LDLR	251909	246223	single nucleotide variant	NM_000527.4(LDLR):c.1586+5G>A	LDLR	25-Apr-17	Familial hypercholesterolemia;not provided	6	19	11224443	G	A	4/25/17	46682	281	2	2	FALSE	FALSE	NA	19:11224443:G:A	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11230777-T-C	LDLR	252083	246378	single nucleotide variant	NM_000527.4(LDLR):c.1855T>C (p.Phe619Leu)	LDLR	16-Dec-16	Familial hypercholesterolemia	4	19	11230777	T	C	12/16/16	46963	0	3	3	FALSE	FALSE	NA	19:11230777:T:C	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11230888-C-A	LDLR	252136	246432	single nucleotide variant	NM_000527.4(LDLR):c.1966C>A (p.His656Asn)	LDLR	16-Dec-16	Familial hypercholesterolemia	5	19	11230888	C	A	12/16/16	46938	25	1	1	FALSE	FALSE	NA	19:11230888:C:A	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11231057-T-C	LDLR	252163	246458	single nucleotide variant	NM_000527.4(LDLR):c.1999T>C (p.Cys667Arg)	LDLR	16-Dec-16	Familial hypercholesterolemia	7	19	11231057	T	C	12/16/16	46877	86	5	5	FALSE	FALSE	NA	19:11231057:T:C	VUS	Insufficient evidence	NA	Pathogenic	Insufficient evidence	High LDL19-11231108-G-A	LDLR	252192	246486	single nucleotide variant	NM_000527.4(LDLR):c.2050G>A (p.Ala684Thr)	LDLR	16-Dec-16	Familial hypercholesterolemia	3	19	11231108	G	A	12/16/16	46512	451	4	4	FALSE	FALSE	NA	19:11231108:G:A	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11230790-T-C	LDLR	369855	354097	single nucleotide variant	NM_000527.4(LDLR):c.1868T>C (p.Ile623Thr)	LDLR	NA	Familial hypercholesterolemia	2	19	11230790	T	C	NA	46963	0	3	3	FALSE	FALSE	NA	19:11230790:T:C	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11227603-G-A	LDLR	373769	360376	single nucleotide variant	NM_000527.4(LDLR):c.1774G>A (p.Gly592Arg)	LDLR	30-Mar-17	Familial hypercholesterolemia	2	19	11227603	G	A	3/30/17	46963	0	2	2	FALSE	FALSE	NA	19:11227603:G:A	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11210913-G-A	LDLR	430745	424291	single nucleotide variant	NM_000527.4(LDLR):c.82G>A (p.Glu28Lys)	LDLR	30-Mar-17	Familial hypercholesterolemia	2	19	11210913	G	A	3/30/17	46963	0	77	77	FALSE	FALSE	NA	19:11210913:G:A	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	High LDL19-11222214-A-C	LDLR	36452	45115	single nucleotide variant	NM_000527.4(LDLR):c.1085A>C (p.Asp362Ala)	LDLR	25-Mar-16	Familial hypercholesterolemia;Hypercholesterolaemia	6	19	11222214	A	C	3/25/16	46949	14	6	6	FALSE	FALSE	NA	19:11222214:A:C	NA	NA	VUS	VUS	NA	High LDL19-11224233-G-A	LDLR	36456	45119	single nucleotide variant	NM_000527.4(LDLR):c.1381G>A (p.Gly461Ser)	LDLR	18-Aug-11	Familial hypercholesterolemia	1	19	11224233	G	A	8/18/11	46898	65	2	2	FALSE	FALSE	NA	19:11224233:G:A	NA	NA	VUS	VUS	NA	High LDL19-11221354-G-A	LDLR	161282	171206	single nucleotide variant	NM_000527.4(LDLR):c.967G>A (p.Gly323Ser)	LDLR	16-Dec-16	Familial hypercholesterolemia;Hypercholesterolaemia	3	19	11221354	G	A	12/16/16	46528	435	3	3	FALSE	FALSE	NA	19:11221354:G:A	NA	NA	VUS	VUS	NA	High LDL19-11224438-G-A	LDLR	237863	243273	single nucleotide variant	NM_000527.4(LDLR):c.1586G>A (p.Gly529Asp)	LDLR	25-Mar-16	Familial hypercholesterolemia	3	19	11224438	G	A	3/25/16	46776	187	1	1	FALSE	FALSE	NA	19:11224438:G:A	NA	NA	VUS	VUS	NA	High LDL19-11227550-G-T	LDLR	237867	243275	single nucleotide variant	NM_000527.4(LDLR):c.1721G>T (p.Arg574Leu)	LDLR	5-Nov-16	Familial hypercholesterolemia	3	19	11227550	G	T	11/5/16	46963	0	1	1	FALSE	FALSE	NA	19:11227550:G:T	NA	NA	VUS	VUS	NA	High LDL19-11215925-C-T	LDLR	251162	245500	single nucleotide variant	NM_000527.4(LDLR):c.343C>T (p.Arg115Cys)	LDLR	30-Mar-17	Familial hypercholesterolemia	4	19	11215925	C	T	3/30/17	46808	155	6	6	FALSE	FALSE	NA	19:11215925:C:T	NA	NA	VUS	VUS	NA	High LDL19-11221336-G-A	LDLR	251567	245891	single nucleotide variant	NM_000527.4(LDLR):c.949G>A (p.Glu317Lys)	LDLR	30-Mar-17	Familial hypercholesterolemia	3	19	11221336	G	A	3/30/17	46906	57	4	4	FALSE	FALSE	NA	19:11221336:G:A	NA	NA	VUS	VUS	NA	High LDL19-11221457-G-A	LDLR	251625	245949	single nucleotide variant	NM_000527.4(LDLR):c.1060+10G>A	LDLR	2-Jan-18	Familial hypercholesterolemia	5	19	11221457	G	A	1/2/18	46878	85	1	1	FALSE	FALSE	NA	19:11221457:G:A	NA	NA	VUS	VUS	NA	High LDL19-11224355-G-A	LDLR	251876	246190	single nucleotide variant	NM_000527.4(LDLR):c.1503G>A (p.Ala501=)	LDLR	30-Mar-17	Familial hypercholesterolemia	2	19	11224355	G	A	3/30/17	46956	7	5	5	FALSE	FALSE	NA	19:11224355:G:A	NA	NA	VUS	VUS	NA	High LDL19-11238715-G-T	LDLR	252290	246576	single nucleotide variant	NM_000527.4(LDLR):c.2343G>T (p.Glu781Asp)	LDLR	25-Mar-16	Familial hypercholesterolemia	2	19	11238715	G	T	3/25/16	46963	0	1	1	FALSE	FALSE	NA	19:11238715:G:T	NA	NA	VUS	VUS	NA	High LDL19-11233969-G-T	LDLR	430797	424341	single nucleotide variant	NM_000527.4(LDLR):c.2260G>T (p.Gly754Trp)	LDLR	30-Mar-17	Familial hypercholesterolemia	1	19	11233969	G	T	3/30/17	46891	72	1	1	FALSE	FALSE	NA	19:11233969:G:T	NA	NA	VUS	VUS	NA	High LDL19-11227552-C-T	LDLR	438324	431955	single nucleotide variant	NM_000527.4(LDLR):c.1723C>T (p.Leu575Phe)	LDLR	2-Jan-18	Familial hypercholesterolemia	2	19	11227552	C	T	1/2/18	46963	0	1	1	FALSE	FALSE	NA	19:11227552:C:T	NA	NA	VUS	VUS	NA	High LDL19-11213408-T-G	LDLR	3685	18724	single nucleotide variant	NM_000527.4(LDLR):c.259T>G (p.Trp87Gly)	LDLR	8-Jun-18	Familial hypercholesterolemia;not provided	11	19	11213408	T	G	6/8/18	46963	0	3	3	FALSE	TRUE	Pathogenic	19:11213408:T:G	NA	NA	NA	Pathogenic	NA	High LDL19-11216263-C-G	LDLR	3690	18729	single nucleotide variant	NM_000527.4(LDLR):c.681C>G (p.Asp227Glu)	LDLR	30-Jun-17	Familial hypercholesterolemia	10	19	11216263	C	G	6/30/17	45557	1406	1	1	FALSE	TRUE	Pathogenic	19:11216263:C:G	NA	NA	NA	Pathogenic	NA	High LDL19-11224052-G-A	LDLR	3694	18733	single nucleotide variant	NM_000527.4(LDLR):c.1285G>A (p.Val429Met)	LDLR	31-Oct-18	Familial hypercholesterolemia	13	19	11224052	G	A	4/6/18	46941	22	1	1	FALSE	TRUE	Pathogenic	19:11224052:G:A	NA	NA	NA	Pathogenic	NA	High LDL19-11231112-C-T	LDLR	3702	18741	single nucleotide variant	NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu)	LDLR	31-Oct-18	Familial hypercholesterolemia;not provided	15	19	11231112	C	T	5/15/18	46553	410	3	3	FALSE	TRUE	Pathogenic	19:11231112:C:T	NA	NA	NA	Pathogenic	NA	High LDL19-11210962-G-A	LDLR	3741	18780	single nucleotide variant	NM_000527.4(LDLR):c.131G>A (p.Trp44Ter)	LDLR	14-Nov-17	Familial hypercholesterolemia	13	19	11210962	G	A	11/14/17	46963	0	1	1	FALSE	TRUE	Pathogenic	19:11210962:G:A	NA	NA	NA	Pathogenic	NA	High LDL19-11231199-G-A	LDLR	3744	18783	single nucleotide variant	NM_000527.4(LDLR):c.2140+1G>A	LDLR	11-Jun-18	Familial hypercholesterolemia	8	19	11231199	G	A	6/11/18	46237	726	1	1	FALSE	TRUE	Pathogenic	19:11231199:G:A	NA	NA	NA	Pathogenic	NA	High LDL19-11223983-C-A	LDLR	3746	18785	single nucleotide variant	NM_000527.4(LDLR):c.1216C>A (p.Arg406=)	LDLR	13-Apr-18	Familial hypercholesterolemia;Familial hypercholesterolemias	6	19	11223983	C	A	4/13/18	46756	207	1	1	FALSE	TRUE	Pathogenic	19:11223983:C:A	NA	NA	NA	Pathogenic	NA	High LDL19-11221442-G-A	LDLR	36450	45113	single nucleotide variant	NM_000527.4(LDLR):c.1055G>A (p.Cys352Tyr)	LDLR	11-Apr-17	Familial hypercholesterolemia;not provided	8	19	11221442	G	A	4/11/17	46938	25	1	1	FALSE	TRUE	Pathogenic	19:11221442:G:A	NA	NA	NA	Pathogenic	NA	High LDL19-11213445-C-G	LDLR	161269	171198	single nucleotide variant	NM_000527.4(LDLR):c.296C>G (p.Ser99Ter)	LDLR	6-May-17	Familial hypercholesterolemia;Hypercholesterolaemia	5	19	11213445	C	G	5/6/17	46963	0	1	1	FALSE	TRUE	Pathogenic	19:11213445:C:G	NA	NA	NA	Pathogenic	NA	High LDL19-11224210-G-A	LDLR	162499	172183	single nucleotide variant	NM_000527.4(LDLR):c.1359-1G>A	LDLR	16-Jan-18	Familial hypercholesterolemia;Hypercholesterolaemia	12	19	11224210	G	A	1/16/18	46870	93	1	1	FALSE	TRUE	Pathogenic	19:11224210:G:A	NA	NA	NA	Pathogenic	NA	High LDL19-11216244-A-G	LDLR	183092	181233	single nucleotide variant	NM_000527.4(LDLR):c.662A>G (p.Asp221Gly)	LDLR	3-Apr-17	Familial hypercholesterolemia;not provided	14	19	11216244	A	G	4/3/17	46280	683	1	1	FALSE	TRUE	Pathogenic	19:11216244:A:G	NA	NA	NA	Pathogenic	NA	High LDL19-11227613-G-A	LDLR	183126	181268	single nucleotide variant	NM_000527.4(LDLR):c.1784G>A (p.Arg595Gln)	LDLR	11-Apr-18	Familial hypercholesterolemia;not provided	8	19	11227613	G	A	4/11/18	46963	0	5	5	FALSE	TRUE	Pathogenic	19:11227613:G:A	NA	NA	NA	Pathogenic	NA	High LDL19-11216084-G-A	LDLR	183136	181228	single nucleotide variant	NM_000527.4(LDLR):c.502G>A (p.Asp168Asn)	LDLR	28-Jun-18	Familial hypercholesterolemia;not provided	7	19	11216084	G	A	6/28/18	46957	6	2	2	FALSE	TRUE	Pathogenic	19:11216084:G:A	NA	NA	NA	Pathogenic	NA	High LDL19-11227576-C-T	LDLR	200921	198015	single nucleotide variant	NM_000527.4(LDLR):c.1747C>T (p.His583Tyr)	LDLR	23-Jan-18	Familial hypercholesterolemia;not provided	10	19	11227576	C	T	1/23/18	46963	0	14	14	FALSE	TRUE	Pathogenic	19:11227576:C:T	NA	NA	NA	Pathogenic	NA	High LDL19-11216011-C-A	LDLR	226325	228138	single nucleotide variant	NM_000527.4(LDLR):c.429C>A (p.Cys143Ter)	LDLR	5-Dec-17	Familial hypercholesterolemia	7	19	11216011	C	A	12/5/17	46951	12	2	2	FALSE	TRUE	Pathogenic	19:11216011:C:A	NA	NA	NA	Pathogenic	NA	High LDL19-11223944-G-A	LDLR	226349	228162	single nucleotide variant	NM_000527.4(LDLR):c.1187-10G>A	LDLR	30-Mar-17	Familial hypercholesterolemia;Familial hypercholesterolemias	10	19	11223944	G	A	3/30/17	46342	621	4	4	FALSE	TRUE	Pathogenic	19:11223944:G:A	NA	NA	NA	Pathogenic	NA	High LDL19-11216213-C-T	LDLR	251335	245672	single nucleotide variant	NM_000527.4(LDLR):c.631C>T (p.His211Tyr)	LDLR	25-Apr-18	Familial hypercholesterolemia	4	19	11216213	C	T	4/25/18	46596	367	2	2	FALSE	TRUE	Pathogenic	19:11216213:C:T	NA	NA	NA	Pathogenic	NA	High LDL19-11216264-G-C	LDLR	251393	245730	single nucleotide variant	NM_000527.4(LDLR):c.682G>C (p.Glu228Gln)	LDLR	15-Aug-17	Familial hypercholesterolemia	6	19	11216264	G	C	8/15/17	45409	1554	4	4	FALSE	TRUE	Pathogenic	19:11216264:G:C	NA	NA	NA	Pathogenic	NA	High LDL19-11222219-T-C	LDLR	251657	245980	single nucleotide variant	NM_000527.4(LDLR):c.1090T>C (p.Cys364Arg)	LDLR	1-Jun-18	Familial hypercholesterolemia	5	19	11222219	T	C	6/1/18	46949	14	1	1	FALSE	TRUE	Pathogenic	19:11222219:T:C	Pathogenic	High Confidence Lab	NA	Pathogenic	High Confidence Lab	High LDL19-11222232-G-A	LDLR	251665	245988	single nucleotide variant	NM_000527.4(LDLR):c.1103G>A (p.Cys368Tyr)	LDLR	5-Jun-18	Familial hypercholesterolemia	8	19	11222232	G	A	6/5/18	46954	9	1	1	FALSE	TRUE	Pathogenic	19:11222232:G:A	NA	NA	NA	Pathogenic	NA	High LDL19-11215918-C-CG	LDLR	440560	434210	duplication	NM_000527.4(LDLR):c.337dup (p.Glu113Glyfs)	LDLR	6-Feb-17	Familial hypercholesterolemia	2	19	11215918	C	CG	2/6/17	46725	238	1	1	FALSE	TRUE	Pathogenic	19:11215918:C:CG	NA	NA	NA	Pathogenic	NA	High LDL19-11211025-A-T	LDLR	225097	226972	single nucleotide variant	NM_000527.4(LDLR):c.190+4A>T	LDLR	23-Oct-17	Familial hypercholesterolemia;Inborn genetic diseases;not provided	8	19	11211025	A	T	10/23/17	46956	7	2	2	FALSE	TRUE	"Pathogenic, Likely pathogenic"	19:11211025:A:T	NA	NA	NA	Likely Pathogenic	NA	High LDL19-11221414-G-A	LDLR	183106	181247	single nucleotide variant	NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser)	LDLR	5-Jul-18	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	15	19	11221414	G	A	7/5/18	46877	86	1	1	FALSE	TRUE	"Pathogenic, Likely pathogenic, Likely pathogenic"	19:11221414:G:A	NA	NA	NA	Likely Pathogenic	NA	High LDL19-11216264-G-A	LDLR	3691	18730	single nucleotide variant	NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	LDLR	19-Jan-18	Familial hypercholesterolemia;not provided	17	19	11216264	G	A	1/19/18	45409	1554	2	2	FALSE	TRUE	"Pathogenic, Pathogenic"	19:11216264:G:A	NA	NA	NA	Pathogenic	NA	High LDL19-11231101-C-A	LDLR	3699	18738	single nucleotide variant	NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter)	LDLR	16-Sep-18	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	17	19	11231101	C	A	9/16/18	46366	597	1	1	FALSE	TRUE	"Pathogenic, Pathogenic"	19:11231101:C:A	NA	NA	NA	Pathogenic	NA	High LDL19-11216232-ATGG-A	LDLR	226329	228142	deletion	NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del)	LDLR	25-Jun-18	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	14	19	11216232	ATGG	A	6/25/18	46578	385	2	2	FALSE	TRUE	"Pathogenic, Pathogenic"	19:11216232:ATGG:A	NA	NA	NA	Pathogenic	NA	High LDL19-11216264-G-T	LDLR	226333	228146	single nucleotide variant	NM_000527.4(LDLR):c.682G>T (p.Glu228Ter)	LDLR	21-May-18	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	11	19	11216264	G	T	5/21/18	45409	1554	1	1	FALSE	TRUE	"Pathogenic, Pathogenic"	19:11216264:G:T	NA	NA	NA	Pathogenic	NA	High LDL19-11221435-C-T	LDLR	226342	228156	single nucleotide variant	NM_000527.4(LDLR):c.1048C>T (p.Arg350Ter)	LDLR	8-May-18	Familial hypercholesterolemia;not provided	11	19	11221435	C	T	5/8/18	46919	44	1	1	FALSE	TRUE	"Pathogenic, Pathogenic"	19:11221435:C:T	NA	NA	NA	Pathogenic	NA	High LDL19-11233979-CT-C	LDLR	226388	228201	deletion	NM_000527.4(LDLR):c.2271delT (p.Leu759Serfs)	LDLR	11-May-17	Familial hypercholesterolemia;not provided	6	19	11233979	CT	C	5/11/17	46877	86	2	2	FALSE	TRUE	"Pathogenic, Pathogenic"	19:11233979:CT:C	NA	NA	NA	Pathogenic	NA	High LDL19-11213417-G-A	LDLR	251105	245448	single nucleotide variant	NM_000527.4(LDLR):c.268G>A (p.Asp90Asn)	LDLR	15-Jun-18	Familial hypercholesterolemia;not provided	8	19	11213417	G	A	6/15/18	46963	0	8	8	FALSE	TRUE	"Pathogenic, Pathogenic"	19:11213417:G:A	NA	NA	NA	Pathogenic	NA	High LDL19-11213450-G-A	LDLR	161266	171199	single nucleotide variant	NM_000527.4(LDLR):c.301G>A (p.Glu101Lys)	LDLR	31-Oct-18	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	14	19	11213450	G	A	11/3/17	46963	0	3	3	FALSE	TRUE	"Pathogenic, Pathogenic, Pathogenic"	19:11213450:G:A	NA	NA	NA	Pathogenic	NA	High LDL19-11227604-G-A	LDLR	161271	171217	single nucleotide variant	NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	LDLR	22-May-18	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	20	19	11227604	G	A	5/22/18	46963	0	3	3	FALSE	TRUE	"Pathogenic, Pathogenic, Pathogenic"	19:11227604:G:A	NA	NA	NA	Pathogenic	NA	High LDL19-11217344-T-A	LDLR	161287	171201	single nucleotide variant	NM_000527.4(LDLR):c.798T>A (p.Asp266Glu)	LDLR	17-May-18	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	16	19	11217344	T	A	5/17/18	46962	1	2	2	FALSE	TRUE	"Pathogenic, Pathogenic, Pathogenic"	19:11217344:T:A	NA	NA	NA	Pathogenic	NA	High LDL19-11227645-G-T	LDLR	161264	171219	single nucleotide variant	NM_000527.4(LDLR):c.1816G>T (p.Ala606Ser)	LDLR	25-Oct-17	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	9	19	11227645	G	T	10/25/17	46963	0	5	5	FALSE	TRUE	Uncertain significance	19:11227645:G:T	NA	NA	NA	VUS	NA	High LDL19-11230798-G-A	LDLR	183127	181269	single nucleotide variant	NM_000527.4(LDLR):c.1876G>A (p.Glu626Lys)	LDLR	27-Sep-17	Familial hypercholesterolemia;not provided;not specified	9	19	11230798	G	A	9/27/17	46963	0	19	19	TRUE	TRUE	Uncertain significance	19:11230798:G:A	VUS	"Conflicting, but VUS by high confidence lab after Jan 2017"	NA	VUS	"Conflicting, but VUS by high confidence lab after Jan 2017"	High LDL19-11227665-C-T	LDLR	224618	226402	single nucleotide variant	NM_000527.4(LDLR):c.1836C>T (p.Ala612=)	LDLR	27-Jun-17	Familial hypercholesterolemia;not provided;not specified	9	19	11227665	C	T	6/27/17	46963	0	10	10	TRUE	TRUE	Uncertain significance	19:11227665:C:T	NA	NA	NA	VUS	NA	High LDL19-11230877-T-C	LDLR	226382	228195	single nucleotide variant	NM_000527.4(LDLR):c.1955T>C (p.Met652Thr)	LDLR	28-Mar-18	Familial hypercholesterolemia	5	19	11230877	T	C	3/28/18	46956	7	1	1	FALSE	TRUE	Uncertain significance	19:11230877:T:C	VUS	"Conflicting, but VUS by high confidence lab after Jan 2017"	NA	VUS	"Conflicting, but VUS by high confidence lab after Jan 2017"	High LDL19-11217315-C-T	LDLR	251446	245782	single nucleotide variant	NM_000527.4(LDLR):c.769C>T (p.Arg257Trp)	LDLR	29-Jun-18	Familial hypercholesterolemia	8	19	11217315	C	T	6/29/18	46962	1	14	14	FALSE	TRUE	Uncertain significance	19:11217315:C:T	NA	NA	NA	VUS	NA	High LDL19-11240278-G-A	LDLR	36462	45125	single nucleotide variant	NM_000527.4(LDLR):c.2479G>A (p.Val827Ile)	LDLR	2-Nov-17	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	16	19	11240278	G	A	11/2/17	46959	4	74	74	FALSE	TRUE	"Uncertain significance, Likely benign"	19:11240278:G:A	NA	NA	NA	VUS	NA	High LDL19-11216172-G-T	LDLR	251309	245646	single nucleotide variant	NM_000527.4(LDLR):c.590G>T (p.Cys197Phe)	LDLR	31-Oct-18	Familial hypercholesterolemia	4	19	11216172	G	T	10/31/18	46963	0	1	1	FALSE	FALSE	NA	19:11216172:G:T	NA	NA	VUS	VUS	"The p.Cys197Phe variant in LDLR has been reported in 1 Portuguese and 1 African American individual with familial hypercholesterolemia (PMID: 20828696, 1301956), and has been identified in 0.006% (1/16232) of African chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs376459828). This variant has also been reported in ClinVar as likely pathogenic (Variation ID: 251309). In vitro functional studies provide some evidence that the p.Cys197Phe variant may slightly impact protein function (PMID: 1301956). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. One additional likely pathogenic variant, resulting in a different amino acid change at the same position, p.Cys197Tyr, has been reported in association with disease in the literature and ClinVar, slightly supporting that a change at this position may not be tolerated (PMID: 27816806, 14993243, 1301956, 23064986, 21376320, 18096825/Variation ID: 200919).  In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PP3, PS4_supporting, PS3_supporting, PM5_supporting (Richards 2015)."	High LDL1-55524222-C-T	PCSK9	201128	196756	single nucleotide variant	NM_174936.3(PCSK9):c.1405C>T (p.Arg469Trp)	PCSK9	7-Dec-17	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3;not specified"	5	1	55524222	C	T	12/7/17	46923	40	124	124	FALSE	TRUE	"Benign, Uncertain significance"	1:55524222:C:T	NA	NA	NA	VUS	NA	High LDL1-55524211-C-T	PCSK9	403292	389422	single nucleotide variant	NM_174936.3(PCSK9):c.1394C>T (p.Ser465Leu)	PCSK9	5-Dec-17	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3;not specified"	3	1	55524211	C	T	12/5/17	46946	17	1	1	TRUE	TRUE	Likely pathogenic	1:55524211:C:T	Likely Pathogenic	High Confidence Lab	NA	VUS	Reassed because PCSK9 is typically for Low LDL 	High LDL1-55509693-G-A	PCSK9	375844	362654	single nucleotide variant	NM_174936.3(PCSK9):c.385G>A (p.Asp129Asn)	PCSK9	16-Dec-16	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3"	3	1	55509693	G	A	12/16/16	46852	111	1	1	FALSE	FALSE	NA	1:55509693:G:A	VUS	"Functional studies show no damaging effect, In silico predicts benign, reassessed as VUS"	NA	Likely Benign	"Functional studies show no damaging effect, In silico predicts benign, reassessed as VUS"	High LDL1-55509631-T-G	PCSK9	375849	362653	single nucleotide variant	NM_174936.3(PCSK9):c.323T>G (p.Leu108Arg)	PCSK9	23-Feb-17	"Familial hypercholesterolemias;Hypercholesterolemia, autosomal dominant, 3"	2	1	55509631	T	G	2/23/17	46921	42	2	2	FALSE	FALSE	NA	1:55509631:T:G	VUS	NA	NA	VUS	NA	High LDL1-55505604-G-A	PCSK9	297692	281418	single nucleotide variant	NM_174936.3(PCSK9):c.94G>A (p.Glu32Lys)	PCSK9	14-Jun-16	Familial hypercholesterolemia;Familial hypobetalipoproteinemia	3	1	55505604	G	A	6/14/16	30240	16723	3	3	FALSE	FALSE	NA	1:55505604:G:A	Likely Pathogenic	"PP1_strong, PS4_moderate, PS3_supporting"	NA	VUS	"PP1_strong, PS4_moderate, PS3_supporting"	High LDL1-55505613-G-T	PCSK9	375848	362650	single nucleotide variant	NM_174936.3(PCSK9):c.103G>T (p.Asp35Tyr)	PCSK9	16-Dec-16	"Hypercholesterolemia, autosomal dominant, 3"	1	1	55505613	G	T	12/16/16	31053	15910	1	1	FALSE	FALSE	NA	1:55505613:G:T	VUS	Conflicting evidence	NA	VUS	Conflicting evidence	High LDL1-55518374-C-T	PCSK9	265933	260609	single nucleotide variant	NM_174936.3(PCSK9):c.709C>T (p.Arg237Trp)	PCSK9	25-Jul-17	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3"	5	1	55518374	C	T	7/25/17	45695	1268	63	63	FALSE	FALSE	NA	1:55518374:C:T	NA	NA	VUS	VUS	NA	High LDL1-55523779-C-A	PCSK9	369875	354066	single nucleotide variant	NM_174936.3(PCSK9):c.1251C>A (p.His417Gln)	PCSK9	16-Dec-16	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3"	2	1	55523779	C	A	12/16/16	46948	15	36	36	FALSE	FALSE	NA	1:55523779:C:A	NA	NA	VUS	VUS	NA	High LDL11-116661656-G-A	APOA5	381733	371260	single nucleotide variant	NM_052968.4(APOA5):c.289C>T (p.Gln97Ter)	APOA5	1-Feb-17	not provided	1	11	116661656	G	A	2/1/17	45369	1594	7	7	FALSE	TRUE	Pathogenic	11:116661656:G:A	Pathogenic	High Confidence Lab	NA	Pathogenic	High Confidence Lab	High triglycerides8-19811733-G-A	LPL	1522	16561	single nucleotide variant	NM_000237.3(LPL):c.644G>A (p.Gly215Glu)	LPL	31-Oct-18	"Hyperapobetalipoproteinemia;Hyperlipoproteinemia, type I;Hyperlipoproteinemia, type I;not provided"	3	8	19811733	G	A	10/31/18	46963	0	13	13	FALSE	FALSE	NA	8:19811733:G:A	NA	NA	VUS	VUS	NA	High triglycerides8-19813529-A-G	LPL	1550	16589	single nucleotide variant	NM_000237.2(LPL):c.953A>G (p.Asn318Ser)	LPL	3-Dec-17	Hyperapobetalipoproteinemia	2	8	19813529	A	G	12/3/17	46957	6	727	721	FALSE	FALSE	NA	8:19813529:A:G	Benign	Found in too many controls	NA	Benign	Found in too many controls	High triglycerides8-19811679-G-A	LPL	521082	511752	single nucleotide variant	NM_000237.2(LPL):c.590G>A (p.Arg197His)	LPL	26-Apr-16	Inborn genetic diseases	1	8	19811679	G	A	4/26/16	46963	0	12	12	FALSE	FALSE	NA	8:19811679:G:A	NA	NA	VUS	VUS	NA	High triglycerides1-156107470-G-A	LMNA	163878	172489	single nucleotide variant	NM_170707.3(LMNA):c.1634G>A (p.Arg545His)	LMNA	23-Apr-18	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1S;Peripheral neuropathy;not provided;not specified"	7	1	156107470	G	A	4/23/18	27473	19490	4	4	TRUE	TRUE	NA	1:156107470:G:A	NA	NA	NA	VUS	"Assessed by HC lab, but reassessed due to high frequency; Uncertain significance - conflicting evidence:  The p.Arg545His variant in LMNA has been reported in 1 individual with lipodystrophy (PMID: 28074886), but has been identified in 0.05% (41/79748) of European (non-Finnish) chromosomes and other populations at lesser frequencies by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP  rs142191737). This variant has been seen in the general population at a frequency high enough to rule out a pathogenic role. This variant has also been reported in ClinVar as having conflicting interpretations of pathogenicity (Variation ID: 163878). In vitro functional studies provide some evidence that the p.Arg545His variant may slightly impact protein function (PMID: 22918509). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. Multiple variants in the same region as p.Arg545His have been reported in association with disease in the literature and the variant is located in a region of LMNA that is thought to be essential to protein folding and stability, suggesting that this variant is in a functional domain and slightly supports pathogenicity (PMID: 28663758). In summary, the clinical significance of the p.Arg545His variant is uncertain. ACMG/AMP Criteria applied: PP3, PS3_supporting, PM1_supporting, BA1 (Richards 2015)."	"Lipodystrophy, MonogenicDM_all"1-156106776-G-A	LMNA	14486	29525	single nucleotide variant	NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln)	LMNA	7-May-18	"Charcot-Marie-Tooth disease, type 2;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Laminopathy;Partial lipodystrophy, Dunnigan;not provided"	7	1	156106776	G	A	5/7/18	46727	236	1	1	FALSE	TRUE	Pathogenic	1:156106776:G:A	NA	NA	NA	Pathogenic	Used HC lab assessment	"Lipodystrophy, MonogenicDM_all"1-156108298-C-T	LMNA	14517	29556	single nucleotide variant	NA	LMNA	21-Dec-17	familial partial lipodystrophy	7	1	156108298	C	T	12/21/17	49960	NA	NA	NA	TRUE	FALSE	NA	1:156108298:C:T	NA	NA	Benign	Benign	"The p.Ser573Leu variant in LMNA has been reported in 1 European individual with familial partial lipodystrophy (PMID: 17250669), but has been identified in 0.04% (4/10102) of Ashkenazi Jewish chromosomes and other populations at slightly lesser frequencies by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs60890628). This variant has been seen in the general population at a frequency high enough to rule out a pathogenic role. This variant has also been reported in ClinVar as having conflicting interpretations of pathogenicity (Variation ID: 14517). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, this variant meets criteria to be classified as benign for familial partial lipodystrophy in an autosomal dominant manner based on its frequency in the general population. ACMG/AMP Criteria applied: BA1 (Richards 2015)."	"Lipodystrophy, MonogenicDM_all"3-12434213-G-A	PPARG	436397	428116	single nucleotide variant	NM_015869.4(PPARG):c.581G>A (p.Arg194Gln)	PPARG	8-Aug-16	Familial partial lipodystrophy 3	1	3	12434213	G	A	8/8/16	46902	61	1	1	FALSE	FALSE	NA	3:12434213:G:A	NA	NA	Likely Pathogenic	Likely Pathogenic	NA	"Lipodystrophy, MonogenicDM_all"3-12475610-C-T	PPARG	8136	23175	single nucleotide variant	NM_015869.4(PPARG):c.1484C>T (p.Pro495Leu)	PPARG	14-Jun-16	"Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension;Familial partial lipodystrophy;Familial partial lipodystrophy 3;Obesity"	2	3	12475610	C	T	6/14/16	46909	54	1	1	FALSE	FALSE	NA	3:12475610:C:T	Pathogenic	"Absent from controls, Well-established functional studies show a deleterious effect, Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease"	NA	Pathogenic	"Absent from controls, Well-established functional studies show a deleterious effect, Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease"	"Lipodystrophy, MonogenicDM_all"3-12475484-AC-A	PPARG	436405	428125	deletion	NM_138712.3(PPARG):c.1277delC (p.Pro426Leufs)	PPARG	22-Jul-16	Familial partial lipodystrophy 3	1	3	12475484	AC	A	7/22/16	46963	0	2	2	FALSE	FALSE	NA	3:12475484:AC:A	VUS	Insufficient evidence	NA	VUS	Insufficient evidence	"Lipodystrophy, MonogenicDM_all"9-135946657-GC-G	CEL	35815	44479	deletion	NM_001807.4(CEL):c.1785delC (p.Val596Cysfs)	CEL	18-Aug-11	"Maturity-onset diabetes of the young, type 8"	1	9	135946657	GC	G	8/18/11	22963	24000	1	1	FALSE	FALSE	NA	9:135946657:GC:G	NA	NA	Likely Pathogenic	Likely Pathogenic	NA	"MODY Extended, MonogenicDM_all"9-135947060-CT-C	CEL	290893	275130	deletion	NM_001807.4(CEL):c.2181delT (p.Val728Cysfs)	CEL	26-Aug-16	"Maturity-onset diabetes of the young, type 8"	1	9	135947060	CT	C	8/26/16	41931	5032	19	17	FALSE	FALSE	NA	9:135947060:CT:C	NA	NA	VUS	VUS	NA	"MODY Extended, MonogenicDM_all"11-17417462-G-T	ABCC8	35614	44279	single nucleotide variant	NM_000352.4(ABCC8):c.4135C>A (p.Arg1379Ser)	ABCC8	9-May-18	Neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy	2	11	17417462	G	T	5/9/18	36071	10892	3	3	FALSE	FALSE	NA	11:17417462:G:T	NA	NA	VUS	VUS	NA	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"11-17417461-C-T	ABCC8	585346	577178	single nucleotide variant	NM_000352.4(ABCC8):c.4136G>A (p.Arg1379His)	ABCC8	28-Sep-17	not provided	1	11	17417461	C	T	9/28/17	36143	10820	4	4	FALSE	FALSE	NA	11:17417461:C:T	NA	NA	Likely Pathogenic	Likely Pathogenic	NA	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"11-17417462-G-A	ABCC8	9105	24144	single nucleotide variant	NM_000352.4(ABCC8):c.4135C>T (p.Arg1379Cys)	ABCC8	1-Mar-16	Diabetes mellitus type 2;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 2	2	11	17417462	G	A	3/1/16	36069	10894	1	1	FALSE	FALSE	NA	11:17417462:G:A	NA	NA	Likely Pathogenic	Likely Pathogenic	NA	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"11-17426099-C-T	ABCC8	35609	44274	single nucleotide variant	NM_000352.4(ABCC8):c.3517G>A (p.Val1173Met)	ABCC8	1-Jan-17	Atrial septal defect;Cardiac shunt;Congestive heart failure;Feeding difficulties;Gastroesophageal reflux;Growth delay;Hypoglycemia;Macrocephalus;Macrotia;Neonatal diabetes mellitus;Neonatal respiratory distress;Short stature;Small for gestational age	2	11	17426099	C	T	1/1/17	46960	3	1	1	FALSE	FALSE	NA	11:17426099:C:T	NA	NA	VUS	VUS	"Uncertain significance - insufficient evidence: The p.Val1173Met variant in ABCC8 has been reported in 1 individual with Monogenic Diabetes in ClinVar (Variation ID: 35609), and has been identified in 0.003098% (4/129110) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs141322087). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a carrier frequency. Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. This variant has also been reported likely pathogenic in ClinVar (Variation ID: 35609). Computational prediction tools and conservation analyses suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Val1173Met variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting, BP4 (Richards 2015)."	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"11-17482160-C-T	ABCC8	35624	44289	single nucleotide variant	NM_000352.4(ABCC8):c.886G>A (p.Gly296Arg)	ABCC8	9-Nov-17	Neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy	2	11	17482160	C	T	11/9/17	46923	40	1	1	FALSE	FALSE	NA	11:17482160:C:T	NA	NA	VUS	VUS	NA	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"11-17434263-G-A	ABCC8	188915	186816	single nucleotide variant	NM_001287174.1(ABCC8):c.2509C>T (p.Arg837Ter)	ABCC8	31-Oct-18	Diabetes mellitus type 2;Leucine-induced hypoglycemia;Permanent neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy;Persistent hyperinsulinemic hypoglycemia of infancy;Transient neonatal diabetes mellitus 2;not provided	5	11	17434263	G	A	10/31/18	46955	8	12	12	FALSE	FALSE	NA	11:17434263:G:A	NA	NA	VUS	NA	Variant assocaited only with Hyperinsulemic hyperglycemia in the literature	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"11-17408737-C-T	KCNJ11	8683	23722	single nucleotide variant	NM_000525.3(KCNJ11):c.902G>A (p.Arg301His)	KCNJ11	11-Dec-17	Islet cell hyperplasia;Islet cell hyperplasia;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3	2	11	17408737	C	T	12/11/17	46921	42	2	2	FALSE	TRUE	Likely pathogenic	11:17408737:C:T	NA	NA	Phenotype of available literature doesn't fit	NA	Reassessed because of high allele count	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"11-17408758-G-A	KCNJ11	211230	207832	single nucleotide variant	NM_000525.3(KCNJ11):c.881C>T (p.Thr294Met)	KCNJ11	18-Aug-17	Islet cell hyperplasia;Islet cell hyperplasia;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3	2	11	17408758	G	A	8/18/17	46936	27	7	7	FALSE	TRUE	NA	11:17408758:G:A	NA	NA	Phenotype of available literature doesn't fit	NA	Reassessed because of high allele count	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"11-17408574-T-TA	KCNJ11	555247	546170	duplication	NM_000525.3(KCNJ11):c.1064dup (p.Leu356Thrfs)	KCNJ11	27-Nov-17	Islet cell hyperplasia;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3	1	11	17408574	T	TA	11/27/17	46919	44	1	1	FALSE	TRUE	Likely pathogenic	11:17408574:T:TA	NA	NA	Phenotype of available literature doesn't fit	NA	Reassessed because of possible phenotype mismatch	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"11-17408795-C-T	KCNJ11	8686	23725	single nucleotide variant	NM_000525.3(KCNJ11):c.844G>A (p.Glu282Lys)	KCNJ11	31-Oct-18	"Diabetes mellitus type 2;Islet cell hyperplasia;Islet cell hyperplasia;Maturity-onset diabetes of the young, type 13;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3"	3	11	17408795	C	T	10/31/18	46963	0	1	1	FALSE	FALSE	NA	11:17408795:C:T	NA	NA	VUS	NA	Phenotype not being assessed for project	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"7-44185189-G-A	GCK	36182	44846	single nucleotide variant	NM_000162.3(GCK):c.1160C>T (p.Ala387Val)	GCK	3-Dec-15	"Maturity-onset diabetes of the young,  type 2;not provided"	2	7	44185189	G	A	12/3/15	41061	5902	1	1	FALSE	FALSE	NA	7:44185189:G:A	NA	NA	VUS	VUS	NA	"MODY, MODY Extended, MonogenicDM_all"7-44185109-T-C	GCK	36188	44852	single nucleotide variant	NM_000162.3(GCK):c.1240A>G (p.Lys414Glu)	GCK	22-May-18	"Maturity-onset diabetes of the young,  type 2;not provided"	2	7	44185109	T	C	5/22/18	43329	3634	1	1	FALSE	FALSE	NA	7:44185109:T:C	NA	NA	Likely Pathogenic	Likely Pathogenic	NA	"MODY, MODY Extended, MonogenicDM_all"7-44192980-C-T	GCK	393453	380272	single nucleotide variant	NM_000162.3(GCK):c.128G>A (p.Arg43His)	GCK	21-Dec-17	Monogenic diabetes;not provided	2	7	44192980	C	T	12/21/17	46963	0	1	1	FALSE	FALSE	NA	7:44192980:C:T	NA	NA	Likely Pathogenic	Likely Pathogenic	"The p.Arg43His variant in GCK has been reported in at least 8 individuals (including 1 German, 1 Slovakian, 1 Swiss, 1 Cyproit, and 1 Hispanic individuals) with Monogenic Diabetes, segregated with disease in 6 affected relatives from 2 family (PMID: 11942313, 24430320, 11942313, 22611063, 22493702, 27106716; DOI:10.3252/pso.eu.54espe.2015; Shammas et al. 2012), and has been identified in 0.002891% (1/34592) of Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs764232985). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a carrier frequency. Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. This variant has also been reported likely pathogenic in ClinVar (Variation ID: 393453). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. One additional pathogenic variant, resulting in a different amino acid change at the same position, p.Arg43Cys, has been reported in association with disease in the literature, supporting that a change at this position may not be tolerated (PMID: 21348868, 30592380, 21521320, 23771172, 19790256, 25015100/Variation ID: 585911). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PS4_Moderate, PM5, PM2_Supporting, PP3, PP1_moderate (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"7-44192019-C-T	GCK	36209	44873	single nucleotide variant	NM_000162.3(GCK):c.214G>A (p.Gly72Arg)	GCK	12-Jul-18	"Maturity-onset diabetes of the young,  type 2;not provided"	3	7	44192019	C	T	7/12/18	46957	6	2	2	FALSE	FALSE	NA	7:44192019:C:T	NA	NA	Likely Pathogenic	Likely Pathogenic	NA	"MODY, MODY Extended, MonogenicDM_all"7-44187430-T-C	GCK	447413	441107	single nucleotide variant	NM_000162.4(GCK):c.682A>G (p.Thr228Ala)	GCK	3-Nov-17	not provided	1	7	44187430	T	C	11/3/17	46453	510	1	1	FALSE	FALSE	NA	7:44187430:T:C	NA	NA	Likely Pathogenic	Likely Pathogenic	NA	"MODY, MODY Extended, MonogenicDM_all"7-44190598-C-T	GCK	36217	44881	single nucleotide variant	NM_000162.3(GCK):c.440G>A (p.Gly147Asp)	GCK	18-Aug-11	"Maturity-onset diabetes of the young,  type 2"	1	7	44190598	C	T	8/18/11	46961	2	1	1	FALSE	FALSE	NA	7:44190598:C:T	NA	NA	VUS	VUS	NA	"MODY, MODY Extended, MonogenicDM_all"7-44190668-C-T	GCK	211073	207484	single nucleotide variant	NM_000162.3(GCK):c.370G>A (p.Asp124Asn)	GCK	1-Jun-17	"Maturity-onset diabetes of the young,  type 2;not specified"	2	7	44190668	C	T	6/1/17	46832	131	1	1	FALSE	FALSE	NA	7:44190668:C:T	NA	NA	VUS	VUS	"Uncertain significance - insufficient evidence: The p.Asp124Asn variant in GCK has been reported in at least 6 individuals (including 1 Polish, 1 Czech, 1 German, and 2 Caucasian individuals) with Monogenic Diabetes (PMID: 27106716, 22773699, 24918535, 20337973; DOI: 10.2337/db18-1509-P), and has been identified in 0.002893% (1/34564) of Latino chromosomes and 0.0008805% (1/113574) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs759072800). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a carrier frequency. This variant has also been reported as a VUS and a likely pathogenic variant in ClinVar (Variation ID: 211073). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The number of missense variants reported in GCK in the general population is lower than expected, suggesting there is little benign variation in this gene and slightly increasing the possibility that a missense variant in this gene may not be tolerated. In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PS4_Moderate, PM2_Supporting, PP2, PP3 (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"7-44187429-G-A	GCK	16134	31173	single nucleotide variant	NM_000162.3(GCK):c.683C>T (p.Thr228Met)	GCK	12-Jun-17	"Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided"	4	7	44187429	G	A	6/12/17	46453	510	1	1	FALSE	TRUE	Pathogenic	7:44187429:G:A	NA	NA	NA	Pathogenic	Used HC lab assessment	"MODY, MODY Extended, MonogenicDM_all"7-44189362-C-T	GCK	36243	44907	single nucleotide variant	NM_000162.3(GCK):c.676G>A (p.Val226Met)	GCK	11-Oct-17	"Maturity-onset diabetes of the young,  type 2;not provided"	4	7	44189362	C	T	10/11/17	46912	51	2	2	FALSE	TRUE	Pathogenic	7:44189362:C:T	NA	NA	NA	Pathogenic	Used HC lab assessment	"MODY, MODY Extended, MonogenicDM_all"7-44189576-G-A	GCK	426122	415104	single nucleotide variant	NM_000162.3(GCK):c.571C>T (p.Arg191Trp)	GCK	7-Nov-17	not provided	2	7	44189576	G	A	10/23/17	46919	44	1	1	FALSE	TRUE	Pathogenic	7:44189576:G:A	NA	NA	NA	Pathogenic	Used HC lab assessment	"MODY, MODY Extended, MonogenicDM_all"7-44228507-C-A	GCK	619964	611361	single nucleotide variant	NM_000162.5(GCK):c.45+1G>T	GCK	17-Aug-17	"Maturity-onset diabetes of the young,  type 2"	1	7	44228507	C	A	8/17/17	46962	1	1	1	FALSE	FALSE	NA	7:44228507:C:A	NA	NA	Pathogenic	Pathogenic	"The c.45+1G>T variant in GCK has been reported in at least 4 individuals with maturity-onset diabetes of the young (MODY) type 2, segregated with disease in 2 affected relatives from 1 family (PMID: 28575730, 11508276), and was absent from large population studies. This variant has also been reported in ClinVar (VariationID: 619964) as Pathogenic by Molecular Diagnostics Laboratory. This variant occurs in the invariant region (+/- 1/2) of the splice consensus sequence and is predicted to cause altered splicing leading to an abnormal or absent protein. Heterozygous loss of function of the GCK gene is an established disease mechanism in MODY type 2. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PVS1, PM2, PS4_supporting (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"12-121432080-C-A	HNF1A	14945	29984	single nucleotide variant	NM_000545.6(HNF1A):c.827C>A (p.Ala276Asp)	HNF1A	7-Jul-17	"Maturity-onset diabetes of the young, type 3;not provided"	2	12	121432080	C	A	7/7/17	44690	2273	2	2	FALSE	TRUE	Likely pathogenic	12:121432080:C:A	Likely Pathogenic	High Confidence Lab	NA	Likely Pathogenic	High Confidence Lab	"MODY, MODY Extended, MonogenicDM_all"12-121434371-C-G	HNF1A	431970	425956	single nucleotide variant	NM_000545.6(HNF1A):c.1135C>G (p.Pro379Ala)	HNF1A	31-Oct-18	not provided	1	12	121434371	C	G	6/23/17	45603	1360	33	31	FALSE	TRUE	Likely pathogenic	12:121434371:C:G	NA	NA	NA	VUS	"Reassessed because of high AC, Adding BA1 changed variant to VUS. Also removed PS3 evidence showing that the variant led to increased bile acid synthesis. Uncertain significance - conflicting evidence: The p.Pro379Ala variant in HNF1A has been reported in 8 individuals with maturity-onset diabetes of the young type 3 (PMID: 19754856, 29207974, 23607861, 30202817, 30155490, 2176128) and has been Identified in 0.07914% (28/35382) of Latino chromosomes, and at lower frequencies in other populations, by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs754729248). This variant has also been reported in ClinVar (VariationID: 431970) as likely pathogenic by GeneDx and as pathogenic by Fulgent Genetics. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. Multiple variants in the same region as p.Pro379Ala have been reported in association with disease in the literature, suggesting that this variant is in a mutational hot spot and supports pathogenicity (PMID: 23348805, 16917892). Three additional likely pathogenic variants, resulting in a different amino acid change at the same position, p.Pro379Thr, p.Pro379Arg, and p.Pro379His, have been reported in association with disease in the literature, supporting that a change at this position may not be tolerated (PMID: 23348805, 16917892, 29666556, 15657605, 15883474, 30293189, 21683639, 26479152, 28012402).  In summary the clinical significance of the p.Pro379Ala variant is uncertain. ACMG/AMP Criteria applied: BA1, PS4_moderate, PM1, PM5, PP3,  (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"12-121432114-CG-C	HNF1A	435424	429378	deletion	NM_000545.6(HNF1A):c.864delG (p.Pro291Glnfs)	HNF1A	23-Dec-16	"Maturity-onset diabetes of the young, type 3"	2	12	121432114	CG	C	12/23/16	41935	5028	34	34	FALSE	FALSE	NA	12:121432114:CG:C	Benign	Found in too many controls	NA	NA	Found in too many controls	"MODY, MODY Extended, MonogenicDM_all"12-121432032-C-T	HNF1A	265436	260011	single nucleotide variant	NM_000545.6(HNF1A):c.779C>T (p.Thr260Met)	HNF1A	16-Feb-18	not provided	2	12	121432032	C	T	2/16/18	45169	1794	1	1	FALSE	FALSE	NA	12:121432032:C:T	Likely Pathogenic	"Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium, Multiple lines of computational evidence support a deleterious effect on the gene or gene product, Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation, Prevalence in affecteds statistically increased over controls, Well-established functional studies show a deleterious effect"	NA	Likely Pathogenic	"Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium, Multiple lines of computational evidence support a deleterious effect on the gene or gene product, Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation, Prevalence in affecteds statistically increased over controls, Well-established functional studies show a deleterious effect"	"MODY, MODY Extended, MonogenicDM_all"12-121435391-C-T	HNF1A	36801	45462	single nucleotide variant	NM_000545.6(HNF1A):c.1424C>T (p.Pro475Leu)	HNF1A	18-Aug-11	"Maturity-onset diabetes of the young, type 3"	1	12	121435391	C	T	8/18/11	45195	1768	2	2	FALSE	FALSE	NA	12:121435391:C:T	NA	NA	VUS	VUS	NA	"MODY, MODY Extended, MonogenicDM_all"12-121437407-A-G	HNF1A	36811	45472	single nucleotide variant	NM_000545.6(HNF1A):c.1745A>G (p.His582Arg)	HNF1A	18-Aug-11	"Maturity-onset diabetes of the young, type 3"	1	12	121437407	A	G	8/18/11	44025	2938	4	4	FALSE	FALSE	NA	12:121437407:A:G	NA	NA	VUS	VUS	"Uncertain significance - insufficient evidence: The p.His582Arg variant in HNF1A has been reported in at least 2 individuals (including 1 Norwegian individual) with Monogenic Diabetes (PMID: 23624530, 27913849, 23348805), and has been identified in 0.01166% (4/34300) of Latino chromosomes, 0.006571% (1/15218) of African chromosomes, and 0.005645% (6/106288) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs193922589). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a carrier frequency. Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. This variant has also been reported likely pathogenic in ClinVar and as a VUS in the literature (Variation ID: 36811; PMID: 27080136). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.His582Arg variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting, PS4_Supporting (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"12-121426776-C-T	HNF1A	36822	45483	single nucleotide variant	NM_000545.6(HNF1A):c.467C>T (p.Thr156Met)	HNF1A	18-Aug-11	"Maturity-onset diabetes of the young, type 3"	1	12	121426776	C	T	8/18/11	46798	165	7	7	FALSE	FALSE	NA	12:121426776:C:T	NA	NA	VUS	VUS	"Uncertain significance - insufficient evidence: The p.Thr156Met variant in HNF1A has been reported in one individual with Monogenic Diabetes in ClinVar (Variation ID: 36822), and has been identified in 0.01960% (6/30616) of South Asian chromosomes and 0.01129% (4/35434) of Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs150513055). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a carrier frequency. Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. This variant has also been reported likely pathogenic in ClinVar (Variation ID: 36822). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Thr156Met variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting, PP3 (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"12-121432080-C-G	HNF1A	36832	45493	single nucleotide variant	NM_000545.6(HNF1A):c.827C>G (p.Ala276Gly)	HNF1A	26-Oct-16	"Maturity-onset diabetes of the young, type 3;not provided"	2	12	121432080	C	G	10/26/16	44692	2271	1	1	FALSE	FALSE	NA	12:121432080:C:G	NA	NA	VUS	VUS	NA	"MODY, MODY Extended, MonogenicDM_all"12-121432125-C-G	HNF1A	36833	45494	single nucleotide variant	NM_000545.6(HNF1A):c.872C>G (p.Pro291Arg)	HNF1A	18-Aug-11	"Maturity-onset diabetes of the young, type 3"	1	12	121432125	C	G	8/18/11	41859	5104	5	5	FALSE	FALSE	NA	12:121432125:C:G	NA	NA	VUS	VUS	"Uncertain significance - insufficient evidence: The p.Pro291Arg variant in HNF1A has been reported in at least one individual with Monogenic Diabetes in ClinVar (Variation ID: 36833), and has been identified in 0.03450% (8/23188) of African chromosomes and 0.0008106% (1/123362) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs193922606). This variant has also been reported likely pathogenic in ClinVar (Variation ID: 36833). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a carrier frequency. Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. Another variant at the same position, p.Pro291Ser, has been reported benign in ClinVar (Variation ID: 447505). In summary, the clinical significance of the p.Pro291Arg variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"12-121416600-C-T	HNF1A	435422	429373	single nucleotide variant	NM_000545.6(HNF1A):c.29C>T (p.Thr10Met)	HNF1A	13-Feb-15	"Maturity-onset diabetes of the young, type 3"	1	12	121416600	C	T	2/13/15	44514	2449	7	7	FALSE	FALSE	NA	12:121416600:C:T	NA	NA	VUS	VUS	"Uncertain significance - insufficient evidence: The p.Thr10Met variant in HNF1A has been reported in at least 3 individuals with Monogenic Diabetes (PMID: 16917892, 18003757, 28938416), and has been identified in 0.01290% (2/15504) of African chromosomes, 0.005794% (2/34520) of Latino chromosomes, and 0.005473% (1/18270) of East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs774637975). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a carrier frequency. Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Thr10Met variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting, PS4_Supporting (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"12-121432117-G-GC	HNF1A	14927	29966	duplication	NM_000545.6(HNF1A):c.872dupC (p.Gly292Argfs)	HNF1A	6-Nov-17	"Clear cell carcinoma of kidney;Diabetes mellitus type 1;Diabetes mellitus, insulin-dependent, 20;Hepatic adenomas, familial;Maturity-onset diabetes of the young, type 3;not provided"	4	12	121432117	G	GC	11/6/17	40326	6637	64	64	FALSE	TRUE	Pathogenic	12:121432117:G:GC	NA	NA	NA	NA	"After reassessment High frequency in gnomAD (https://gnomad.broadinstitute.org/variant/12-121432117-G-GC). Variant is a frameshift (insertion of C) in a hompolymer. In gnomAD it failed random forest for exomes and genomes. It is described as path by multiple submitters in ClinVar. It reaches pathogenic, but reads in gnomAD and AMP T2D carriers look suspicious. Variant excluded in LoF curation as homopolymer error. The variant may well be real in some individuals, we can't trust the overall genotyping so this variant was excluded from the analysis."	"MODY, MODY Extended, MonogenicDM_all"12-121431481-C-T	HNF1A	420064	408541	single nucleotide variant	NM_000545.6(HNF1A):c.685C>T (p.Arg229Ter)	HNF1A	13-Mar-17	not provided	1	12	121431481	C	T	3/13/17	46572	391	1	1	FALSE	TRUE	Pathogenic	12:121431481:C:T	Pathogenic	High Confidence Lab	NA	Pathogenic	High Confidence Lab	"MODY, MODY Extended, MonogenicDM_all"12-121432065-G-A	HNF1A	449403	444937	single nucleotide variant	NM_000545.6(HNF1A):c.812G>A (p.Arg271Gln)	HNF1A	14-Aug-17	not provided	1	12	121432065	G	A	8/14/17	44906	2057	1	1	FALSE	TRUE	Pathogenic	12:121432065:G:A	NA	NA	NA	Pathogenic	Used HC lab assessment	"MODY, MODY Extended, MonogenicDM_all"20-43042354-C-T	HNF4A	9212	24251	single nucleotide variant	NM_175914.4(HNF4A):c.340C>T (p.Arg114Trp)	HNF4A	12-Dec-17	"Maturity-onset diabetes of the young,  type 1;not provided;not specified"	3	20	43042354	C	T	12/12/17	46238	725	5	5	TRUE	FALSE	NA	20:43042354:C:T	VUS	"Conflicting, but VUS by high confidence lab after Jan 2017"	NA	VUS	"Uncertain Significance - Conflicting Evidence: BS2, PP3; also VUS by high confidence lab (GeneDx). "	"MODY, MODY Extended, MonogenicDM_all"20-43042375-A-G	HNF4A	36349	45013	single nucleotide variant	NM_000457.4(HNF4A):c.427A>G (p.Ser143Gly)	HNF4A	20-Mar-17	"Maturity-onset diabetes of the young,  type 1;not specified"	2	20	43042375	A	G	3/20/17	46198	765	1	1	TRUE	FALSE	NA	20:43042375:A:G	NA	NA	VUS	VUS	"Uncertain significance - insufficient evidence: The p.Ser143Gly variant in HNF4A has been reported in 1 individual with Maturity-Onset Diabetes of the Young in ClinVar (Variation ID: 36349), and has been identified in 0.01145% (13/113552) of European (non-Finnish) chromosomes and 0.002894% (1/34554) of Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs193922472). This variant has also been reported in an individual without diabetes (PMID: 24097065). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a carrier frequency. Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. This variant has also been reported as a VUS and a likely pathogenic variant in ClinVar (Variation ID: 36349). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Ser143Gly variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting, PP3 (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"20-43048458-G-C	HNF4A	36360	45024	single nucleotide variant	NM_000457.4(HNF4A):c.834G>C (p.Glu278Asp)	HNF4A	18-Aug-11	"Maturity-onset diabetes of the young,  type 1"	1	20	43048458	G	C	8/18/11	46962	1	2	2	FALSE	FALSE	NA	20:43048458:G:C	NA	NA	VUS	VUS	"Uncertain significance - insufficient evidence: The p.Glu278Asp variant in HNF4A has been reported in one individual with suspected Maturity-Onset Diabetes of the Young (PMID: 26059258), and has been identified in 0.004005% (1/24968) of African chromosomes and 0.0007741% (1/129180) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs193922477). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a carrier frequency. Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. This variant has also been reported likely pathogenic in ClinVar and likely benign in the literature (Variation ID: 36360; PMID: 26059258). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Glu278Asp variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"20-43052756-C-T	HNF4A	36364	45028	single nucleotide variant	NM_000457.4(HNF4A):c.991C>T (p.Arg331Cys)	HNF4A	21-Dec-16	"Hyperinsulinemia;Maturity-onset diabetes of the young,  type 1;not specified"	3	20	43052756	C	T	12/21/16	44562	2401	1	1	FALSE	FALSE	NA	20:43052756:C:T	NA	NA	VUS	VUS	NA	"MODY, MODY Extended, MonogenicDM_all"20-43052763-G-A	HNF4A	586023	577863	single nucleotide variant	NM_000457.4(HNF4A):c.998G>A (p.Arg333His)	HNF4A	22-Nov-17	"Maturity-onset diabetes of the young,  type 1;not provided"	2	20	43052763	G	A	11/22/17	46948	15	1	1	FALSE	FALSE	NA	20:43052763:G:A	NA	NA	VUS	VUS	"Uncertain significance - insufficient evidence: Variant has BS1 frequency 0.005% but only 1 het on gnomad--south asian population. If PM2 it is LP, if not it is VUS. The p.Arg333His variant in HNF4A has been reported in at least 3 individuals with maturity-onset diabetes of the young type 1 (MODY1) (PMID: 24947580, 25414397, 26059258) and has been Identified in 0.005451% (1/18346) of East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs1375557127). In vitro functional studies demonstrating reduced relative activity in cells transfected with the variant provide some evidence that the p.Arg333His variant may slightly impact protein function (PMID: 23485969). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The p.Arg333His variant is located in a region of HNF1A that is essential to ligand binding and stability, suggesting that this variant is in a functional domain and slightly supports pathogenicity (PMID: 23485969). In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: BS1, PM2, PP3, PS4_supporting, PS3_supporting, PM1_supporting (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"13-28494501-G-A	PDX1	8859	23898	single nucleotide variant	NM_000209.3(PDX1):c.226G>A (p.Asp76Asn)	PDX1	5-Feb-18	"Diabetes mellitus type 2;Maturity onset diabetes mellitus in young;Maturity-onset diabetes of the young, type 4;Monogenic diabetes;not specified"	6	13	28494501	G	A	2/5/18	22473	24490	98	98	TRUE	FALSE	NA	13:28494501:G:A	NA	NA	Benign	Benign	"The p.Asp76Asn variant in PDX1 (sometimes called IPF1) has been reported in at least 32 individuals with Maturity-Onset Diabetes of the Young (PMID: 15277425, 10545531, 10545530, 17592437), and has been identified in 0.4909% (336/68440) of European (non-Finnish) chromosomes, including 2 homozygotes, by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs137852783). Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. However, this variant does not segregate with disease in many families, including sibling pairs (PMID: 10545531, 15277425). This variant has also been reported as a benign variant, likely benign variant, VUS, likely pathogenic variant, and risk factor for diabetes in ClinVar (Variation ID: 8859). In vitro functional studies provide some evidence that the p.Asp76Asn variant may slightly impact protein function, but this evidence is not conclusive (PMID: 10545531). These types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, this variant meets criteria to be classified as benign for Maturity-Onset Diabetes of the Young in an autosomal dominant manner based on a higher than expected frequency in control cohorts and nonsegregation with MODY. ACMG/AMP Criteria applied: BS2, BS4, BP4 (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"13-28498711-C-T	PDX1	36411	45074	single nucleotide variant	NM_000209.3(PDX1):c.725C>T (p.Pro242Leu)	PDX1	28-Mar-16	"Maturity-onset diabetes of the young, type 4;not specified"	2	13	28498711	C	T	3/28/16	41198	5765	24	24	FALSE	FALSE	NA	13:28498711:C:T	NA	NA	Benign	Benign	"The p.Pro242Leu variant in PDX1 has been reported in at least 1 Asian individual with maturity-onset diabetes of the young type 4 (PMID: 27420379), and has been identified in 0.2% (124/58140) of European (non-Finnish) chromosomes and multiple other populations at lower frequencies by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs193922358). This variant has been seen in the general population at a frequency high enough to rule out a pathogenic role. This variant has also been reported in ClinVar as having conflicting interpretations of pathogenicity (Variation ID: 36411). Computational prediction tools, including splice predictors, and conservation analyses suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, this variant meets criteria to be classified as benign for MODY type 4 in an autosomal dominant manner based on computational tool predictions and the frequency of this variant in multiple populations. ACMG/AMP Criteria applied: BP4, BA1 (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"13-28494372-C-A	PDX1	36414	45077	single nucleotide variant	NM_000209.3(PDX1):c.97C>A (p.Pro33Thr)	PDX1	10-Jun-16	"Maturity-onset diabetes of the young, type 4;not provided"	2	13	28494372	C	A	6/10/16	38775	8188	96	96	FALSE	FALSE	NA	13:28494372:C:A	NA	NA	VUS	VUS	"Uncertain significance - conflicting evidence: The p.Pro33Thr variant in PDX1 has been reported in 1 individual with maturity-onset diabetes of the young type 4 (PMID: 16092045), but has been identified in 0.7% (164/22330) of South Asian chromosomes as well as other populations at lesser frequencies by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs192902098). This variant has also been reported in ClinVar as having conflicting interpretations of pathogenicity (Variation ID: 36414). In vitro functional studies provide some evidence that the p.Pro33Thr variant may impact protein function (PMID: 16092045, 30930126). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. ACMG/AMP Criteria applied: BA1, PS3_moderate, PP3 (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"13-28494327-T-C	PDX1	8862	23901	single nucleotide variant	NM_000209.3(PDX1):c.52T>C (p.Cys18Arg)	PDX1	10-Oct-16	Diabetes mellitus type 2;not provided	2	13	28494327	T	C	10/10/16	41938	5025	3	3	FALSE	FALSE	NA	13:28494327:T:C	NA	NA	VUS	VUS	"Uncertain significance - insufficient evidence:  Variant seems to be somewhat damaging but with very low penetrance, also, maybe use BS1? Seems mostly associated with T2D than MODY. The p.Cys18Arg variant in PDX1 has been reported in at least 3 individuals with type 2 diabetes mellitus (PMID: 10545530, 27879214; DOI: 10.7324/JABB.2013.1205), and has been identified in 0.02173% (15/69030) of European (non-Finnish) chromosomes, 0.01066% (2/18762) of European (Finnish) chromosomes, and 0.003943% (1/25360) of Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs137852785). In vitro functional studies provide some evidence that the p.Cys18Arg variant may slightly impact protein function, resulting in moderately decreased binding activity to the insulin promoter and decreased transcription of insulin in response to hyperglycemia  (PMID: 30930126, 10545530). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The p.Cys18Arg variant did not segregate with type 2 diabetes mellitus in 3 affected relatives of  individuals with the variant, suggesting that this variant is not pathogenic for type 2 diabetes mellitus (PMID: 10545530). The variant is located in a region of PDX1 that is important for protein binding, suggesting that this variant is in a functional domain and slighly supports pathogenicity (PMID: 27879214).  In summary, the clinical significance of the p.Cys18Arg variant is uncertain. ACMG/AMP Criteria applied: BS4, PP3, PS4_supporting, PS3_supporting, PM1_supporting (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all"17-36070609-C-T	HNF1B	379811	376001	single nucleotide variant	NM_000458.3(HNF1B):c.1108G>A (p.Gly370Ser)	HNF1B	17-Apr-17	not provided;not specified	2	17	36070609	C	T	4/17/17	46960	3	26	26	TRUE	FALSE	NA	17:36070609:C:T	VUS	"Conflicting, but VUS by high confidence lab after Jan 2017"	NA	VUS	"Uncertain Significance - Insufficient Evidence: PP1, PM2; also VUS by high confidence lab (GeneDx and EGL) after Jan 2017"	"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes"17-36091625-G-A	HNF1B	36837	45498	single nucleotide variant	NM_000458.3(HNF1B):c.1006C>T (p.His336Tyr)	HNF1B	18-Aug-11	"Familial hypoplastic, glomerulocystic kidney"	1	17	36091625	G	A	8/18/11	46280	683	3	3	FALSE	FALSE	NA	17:36091625:G:A	NA	NA	VUS	VUS	"Uncertain significance - insufficient evidence: The p.His336Tyr variant in HNF1B has been reported in at least 1 individual with Renal Cysts and Diabetes Syndrome in ClinVar (Variation ID: 377055), and has been identified in 0.02611% (9/34468) of Latino chromosomes and 0.0008848% (1/113020) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs138986885). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a carrier frequency. Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. This variant has also been reported likely pathogenic in ClinVar (Variation ID: 36837). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.His336Tyr variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting, PP3 (Richards 2015)."	"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes"17-36104736-G-A	HNF1B	36840	45501	single nucleotide variant	NM_000458.3(HNF1B):c.140C>T (p.Pro47Leu)	HNF1B	18-Aug-11	"Familial hypoplastic, glomerulocystic kidney"	1	17	36104736	G	A	8/18/11	46565	398	6	6	FALSE	FALSE	NA	17:36104736:G:A	NA	NA	VUS	VUS	NA	"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes"17-36091682-C-A	HNF1B	36854	45515	single nucleotide variant	NM_000458.3(HNF1B):c.949G>T (p.Ala317Ser)	HNF1B	18-Aug-11	"Familial hypoplastic, glomerulocystic kidney"	1	17	36091682	C	A	8/18/11	46955	8	3	3	FALSE	FALSE	NA	17:36091682:C:A	NA	NA	VUS	VUS	NA	"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes"18-58039089-C-T	MC4R	327713	347739	single nucleotide variant	NM_005912.2(MC4R):c.494G>A (p.Arg165Gln)	MC4R	14-Jun-16	Obesity	1	18	58039089	C	T	6/14/16	46951	12	2	2	FALSE	FALSE	NA	18:58039089:C:T	NA	NA	Likely Pathogenic	Likely Pathogenic	NA	Obesity18-58039134-G-A	MC4R	435829	430076	single nucleotide variant	NM_005912.2(MC4R):c.449C>T (p.Thr150Ile)	MC4R	18-Oct-16	"Obesity;Obesity, autosomal dominant"	2	18	58039134	G	A	10/18/16	46957	6	8	8	FALSE	FALSE	NA	18:58039134:G:A	NA	NA	Likely Pathogenic	Likely Pathogenic	NA	Obesity18-58038834-A-T	MC4R	549551	540034	single nucleotide variant	NM_005912.2(MC4R):c.749T>A (p.Leu250Gln)	MC4R	10-Mar-17	Monogenic diabetes;Obesity	2	18	58038834	A	T	3/10/17	46954	9	1	1	FALSE	FALSE	NA	18:58038834:A:T	NA	NA	Likely Pathogenic	Likely Pathogenic	NA	Obesity18-58038670-G-A	MC4R	586138	577690	single nucleotide variant	NM_005912.2(MC4R):c.913C>T (p.Arg305Trp)	MC4R	8-Sep-17	not provided	1	18	58038670	G	A	9/8/17	46956	7	2	2	FALSE	FALSE	NA	18:58038670:G:A	NA	NA	VUS	VUS	NA	Obesity18-58039402-C-T	MC4R	435831	430078	single nucleotide variant	NM_005912.2(MC4R):c.181G>A (p.Glu61Lys)	MC4R	30-Aug-16	"Obesity;Obesity, autosomal dominant;not provided"	3	18	58039402	C	T	8/30/16	46960	3	1	1	FALSE	FALSE	NA	18:58039402:C:T	Likely Pathogenic	"PM2 (Absent in population databases) upgraded in strength to Strong, PS4 (Prevalence in affecteds statistically increased over controls) upgraded in strength to Very Strong"	NA	Likely Pathogenic	"PM2 (Absent in population databases) upgraded in strength to Strong, PS4 (Prevalence in affecteds statistically increased over controls) upgraded in strength to Very Strong"	Obesity18-58039478-G-T	MC4R	14318	29357	single nucleotide variant	NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter)	MC4R	14-Aug-18	Obesity;Schizophrenia;not provided	7	18	58039478	G	T	6/14/16	46945	18	6	6	FALSE	FALSE	Pathogenic	18:58039478:G:T	NA	NA	Pathogenic	Pathogenic	NA	Obesity18-58039203-G-A	MC4R	14336	29375	single nucleotide variant	NM_005912.2(MC4R):c.380C>T (p.Ser127Leu)	MC4R	25-May-17	Obesity;not provided;not specified	6	18	58039203	G	A	5/25/17	46956	7	18	18	TRUE	FALSE	NA	18:58039203:G:A	Likely Pathogenic	Conflicting evidence	Likely Pathogenic	Likely Pathogenic	NA	Obesity18-58039060-C-T	MC4R	14330	29369	single nucleotide variant	NM_005912.2(MC4R):c.523G>A (p.Ala175Thr)	MC4R	16-Mar-11	Obesity	2	18	58039060	C	T	3/16/11	46958	5	45	45	FALSE	FALSE	NA	18:58039060:C:T	VUS	Conflicting evidence	NA	VUS	Conflicting evidence	Obesity18-58038687-G-T	MC4R	36488	45150	single nucleotide variant	NM_005912.2(MC4R):c.896C>A (p.Pro299His)	MC4R	18-Aug-11	Obesity	1	18	58038687	G	T	8/18/11	46960	3	3	3	FALSE	FALSE	NA	18:58038687:G:T	VUS	Conflicting evidence	NA	VUS	Conflicting evidence	Obesity18-58038777-A-T	MC4R	36486	45148	single nucleotide variant	NM_005912.2(MC4R):c.806T>A (p.Ile269Asn)	MC4R	14-Mar-17	Obesity;not specified	3	18	58038777	A	T	3/14/17	46956	7	241	237	TRUE	FALSE	NA	18:58038777:A:T	NA	NA	VUS	VUS	NA	Obesity18-58039422-A-G	MC4R	492861	485792	single nucleotide variant	NM_005912.2(MC4R):c.161T>C (p.Leu54Pro)	MC4R	4-May-17	Obesity	1	18	58039422	A	G	5/4/17	46962	1	2	2	FALSE	FALSE	NA	18:58039422:A:G	NA	NA	VUS	VUS	NA	Obesity18-58038826-C-T	MC4R	492862	485791	single nucleotide variant	NM_005912.2(MC4R):c.757G>A (p.Val253Ile)	MC4R	4-Mar-14	Obesity	1	18	58038826	C	T	3/4/14	46956	7	7	7	FALSE	FALSE	NA	18:58038826:C:T	NA	NA	VUS	VUS	NA	Obesity